Targeted discovery of gut microbiome-remodeling compounds for the treatment of systemic inflammatory response syndrome/Experiment 25/Signature 2
From BugSigDB
Reviewed Marked as Reviewed by Svetlana up on 2024-12-9
Source: Figure S5D
Description: the relative abundance in genus levels after cocktail treatment
Abundance in Group 1: decreased abundance in D2.1 (gut microbiome remodeling compound)
| NCBI | Quality Control | Links |
|---|---|---|
| Escherichia/Shigella sp. |
Revision editor(s): Ifeanyisam, Victoria
